Scioto Biosciences Closes $1.8M in Series A Financing, Receives NIH and State of Indiana Grants Funding to Support Launch of New Microbiome Platform Technology INDIANAPOLIS, May 21, 2018-- Scioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced it has closed on $1.8M in Series A financing to support the launch of its new microbiome platform technology.